{"transactions":[{"id":4627797,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-28T21:15:10.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":54750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on September 24, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":54750,"derivative":{"exercise_price":3.39,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":54750},"source":{"system":"sec-edgar","filing":"0002109299-26-000009","document":"form4-09282026_050906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2109299/000210929926000009/form4-09282026_050906.xml","form_type":"4"}},{"id":4627796,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-28T21:15:10.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":2714,"price":3.579,"value":9713.406,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,500 Restricted Stock Units."}],"balance_after":84908,"source":{"system":"sec-edgar","filing":"0002109299-26-000009","document":"form4-09282026_050906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2109299/000210929926000009/form4-09282026_050906.xml","form_type":"4"}},{"id":720539,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:48:24.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":22306,"price":4.42,"value":98592.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of performance Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.341 to $4.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 49,500 RSUs.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":82194,"source":{"system":"sec-edgar","filing":"0002109299-26-000007","document":"form4-07012026_100718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000210929926000007/form4-07012026_100718.xml","form_type":"4"}},{"id":720538,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:48:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":104500,"source":{"system":"sec-edgar","filing":"0002109299-26-000007","document":"form4-07012026_100718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000210929926000007/form4-07012026_100718.xml","form_type":"4"}},{"id":900235,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T21:55:06.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":297000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on January 20, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":297000,"derivative":{"exercise_price":6.31,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":297000},"source":{"system":"sec-edgar","filing":"0002109299-26-000004","document":"form4-02172026_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000210929926000004/form4-02172026_040201.xml","form_type":"4"}},{"id":900234,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":33740,"kind":"person","name":"Bhalla Narinder Pal","position":1,"cik":"0002109299","reported_name":"Bhalla Narinder Pal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T21:55:06.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,500 RSUs."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0002109299-26-000004","document":"form4-02172026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000210929926000004/form4-02172026_040201.xml","form_type":"4"}}]}